CAS: 3208-16-0; 2-Ethylfuran

相似化合物

4229-91-8 3208-16-0 1703-52-2

上下游产品

CAS号1192-62-7 2-乙酰基呋喃 | CAS号1487-18-9 2-Ethenylfuran | CAS号83726-18-5 hex-2-ene-1,4-diol | CAS号6728-26-3 反-2-己烯醛 | CAS号9004-34-6 微晶纤维素 | CAS号17427-08-6 4-hydroxy-2-hexenal | CAS号13129-26-5 1-(3-FURYL)-1-E... | CAS号25346-59-2 hexane-1,4-diol | CAS号16432-53-4 1,4-Hexanediol | CAS号56311-37-6 5-乙基呋喃-2-羧酸 | CAS号24119-98-0 1-(5-Ethyl-2-fu... | CAS号2492-43-5 4-oxohex-2-enal | CAS号28200-51-3 3-乙基吡嗪 | CAS号589-38-8 3-己酮 | CAS号133712-90-0 2,6-diethylpyri... | CAS号23074-10-4 5-乙基-2-糠醛 | CAS号2313-01-1 2(3H)-Furanone,... | CAS号1487-12-3 1,1':2',1''-Ter...

1,4-己烷二醇置于吡啶,Chromium(Vi) Oxide,对甲苯磺酸体系中,用 氯仿 用作溶剂,化学反应生成2-乙基呋喃
参考文献:Cormier,Russell A.; Grosshans,Cheryl A.; Skibbe,Sandra L.,Synthetic Communications,1988,Vol. 18,# 7,P. 677-680
标题:Cormier,Russell A.; Grosshans,Cheryl A.; Skibbe,Sandra L.,Synthetic Communications,1988,Vol. 18,# 7,P. 677-680

专利信息

专利号:US-7279572-B2
优先权日:2003-05-22
标题:Process for the 2-stage synthesis of hexanitrohexaazaisowurtzitane starting from a primary amine
发明人：CAGNON GUY; ECK GENEVIEVE; HERVE GREGOIRE; JACOB GUY
权利人:SNPE MATERIAUX ENERGETIQUES
摘要:A subject-matter of the present invention is a novel process for the synthesis of hexanitrohexaazaisowurtzitane (HNIW), a compound of use as energetic filler in powders, propellants and explosives. n This process comprises a first stage of reaction of an α,β-dicarbonyl derivative with a primary amine which makes it possible to form a hexasubstituted hexaazaisowurtzitane derivative. n The HNIW is subsequently obtained directly, in a single reaction stage, by nitration of the hexasubstituted hexaazaisowurtzitane derivative. n This process, in only 2 stages starting from a primary amine, is particularly simple and inexpensive.

专利号:US-7173059-B2
优先权日:2003-05-08
标题:Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same
发明人：ALBIZATI KIM FRANCIS; BABU SRINIVASAN
权利人:AGOURON PHARMA
摘要:Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds, useful in the synthesis of HIV-protease inhibitors and methods of preparing these intermediate compounds are disclosed.

专利号:US-2013338369-A1
优先权日:2011-03-07
标 题 :Process for the Synthesis of Aminobiphenylene
发明人：HEINRICH MARKUS; PRATSCH GERALD
权利人:HEINRICH MARKUS; PRATSCH GERALD; BASF SE
摘要:The present invention relates to a process for the synthesis of 2-aminobiphenylene and derivatives thereof by reacting a benzene diazonium salt with an aniline compound under basic reaction conditions.

专利号:US-6472534-B2
优先权日:1999-10-21
标 题:Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
发明人：BORER BENNETT C; ZOOK SCOTT E; BUSSE JULIETTE K
权利人:AGOURON PHARMA
摘要:Methods for the preparation of chemical intermediates in the synthesis of HIV-protease inhibitors related to and including nelfinavir mesylate are disclosed. The method of this invention comprises converting tetrohydran derivatives into oxazolines to provide key reaction intermediates for the preparation of nelfinavir. Also disclosed is a method for the preparation of a chiral amino alcohol from an epoxy-tetrahydrofuran.

专利号:US-6765117-B2
优先权日:1997-10-24
标题:Process for stereoselective synthesis of prostacyclin derivatives
发明人：MORIARTY ROBERT M; PENMASTA RAJU; GUO LIANG; RAO MUNAGALA S; STASZEWSKI JAMES P
权利人:UNITED THERAPEUTIC CORP
摘要:An improved method is described for making 9-deoxy-PGF 1 -type compounds. In contrast to the prior art, the method is stereoselective and requires fewer steps than the known methods for making these compounds. The invention also relates to novel intermediates prepared during the synthesis of the 9-deoxy-PGF 1 -type compounds.

专利号:US-4894385-A
优先权日:1985-01-16
标 题:Imidazole derivatives as inhibitors of TXA2 synthesis
发明人：KAWAMOTO ISAO; ENDO ROKURO; MATSUDA KEIICHI; USHIYAMA SHIGERU; OSHIMA TAKESHI
权利人:SANKYO CO
摘要:Compounds of formula (I): ##STR1## (wherein n is 0, 1 or 2 and R 1 , R 2 , R 4 , R 5 , R 6 , X, Y and Z are a variety of groups and atoms) have the ability to inhibit the synthesis of thromboxane A 2 and hence are useful in the treatment or prophylaxis of thrombotic conditions.